# Insulin Glargine in Type 2 Diabetes Mellitus

> **NCT00311818** · PHASE4 · COMPLETED · sponsor: **Sanofi**

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin glargine

## Key facts

- **NCT ID:** NCT00311818
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311818, "Insulin Glargine in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00311818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*